- 中文名
- (S)-2-(8-氟-3-(2-甲氧基-5-(三氟甲基)苯基)-2-(4-(3-甲氧基苯基)哌嗪-1-基)-3,4-二氢喹唑啉-4-基)乙酸甲酯 (2S,3S)-2,3-双((4-甲基苯甲酰基)氧基)丁二酸盐
- 英文名
- Methyl (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate
- CAS号
- 917389-30-1
- 分子式
- C50H48F4N4O12
- 分子量
- 972.92
- 中文别名
- 莱特莫韦标准品ALT; {(4S)-8-氟-2-[4-(3-甲氧基苯基)哌嗪-1-基]-3-(2-甲氧基-5-(三氟甲基)苯基)-3,4-二氢喹唑啉-4-基}乙酸甲酯D-(+)-二对甲基苯甲酰酒石酸盐; 莱特莫韦杂质33
- 英文别名
- Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1); (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid {(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-(trifluormethyl)phenyl)-3,4-dihydroquinazolin-4-yl}acetic acid methyl ester; LeterMovir-004-salt; Mupiravir intermediate; Letermovir Impurity 33; Letermovir Impurity(Di-p-toluoyl-L-tartaric acid); (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid-{(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazine-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazoline-4-yl}methyl acetate; (S)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate mono-(2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate; [(S)-8-fluoro-2-[4-(3-methoxy-phenyl)-piperazin-1-yl]-3-(2-methoxy-5-trifluoromethyl-phenyl)-3,4-dihydro-quinazolin-4-yl]-acetic acid methyl ester (2S,3S)-2,3-bis-(4-methyl-benzoyloxy)-succinic acid salt
